WANG, Lu. Clinical Progress of Targeted KRAS Drugs Combined with Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer. Transactions on Materials, Biotechnology and Life Sciences, [S. l.], v. 8, p. 397–402, 2025. DOI: 10.62051/rq7x6r98. Disponível em: https://tmbls.org/index.php/ojs/article/view/65. Acesso em: 2 jul. 2026.